Navigation Links
UAE Analyses HIV Policies to Plan National Strategy

The United Arab Emirates (UAE) is analysing its HIV/AIDS policies to develop a five-year national strategy concerning the killer disease, Gulf News// reported Thursday.

Officials from governmental agencies as well as international organisations, including the Red Crescent Authority, UNAIDS and UNDP, discussed the HIV/AIDS situation in the country at a workshop.

The workshop was the first of many steps needed to formulate a national response to the disease, said Nada Al Marzouqi, head of the UAE HIV Committee at the health ministry.

According to official statistics, 645 reported cases of AIDS were reported among the UAE nationals at the end of 2006.

Source-Xinhua
'"/>




Page: 1

Related medicine news :

1. Using Body Mass Index Skews Analyses on Obesity Rates
2. A New Study Analyses Benefits Of Statin Drug
3. National Lung Study in the process
4. Indian Nationals with Foreign Medical Degrees can now practice in India
5. Hepatitis B Vaccine To Be Included In National Immunization Programme
6. UK Govt Says On Course For National Chlamydia Screening
7. Mexico and US border attain a new outlook due to BiNational Sustainability Laboratory
8. India extends National TB Control Program
9. President and Founder of National Obesity Forum Resigns
10. Hwang Woo Suk Suspended By Seoul National University
11. Indian National in Saudi Jail will be released soon
Post Your Comments:
Breaking Medicine Technology:China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 2China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 3New National Pharmaceutical Council Report Provides Guidance on Evaluating Comparative Effectiveness Studies 2Perceptive Informatics Introduces Greater Convergence Between EDC and RTSM Solutions in Its eClinical Suite 2Perceptive Informatics Introduces Greater Convergence Between EDC and RTSM Solutions in Its eClinical Suite 3Perceptive Informatics Introduces Greater Convergence Between EDC and RTSM Solutions in Its eClinical Suite 4Perceptive Informatics Introduces Greater Convergence Between EDC and RTSM Solutions in Its eClinical Suite 5New Productivity Suite From Varian Inc Increases Throughput for NMR Laboratories 14169 1New Productivity Suite From Varian Inc Increases Throughput for NMR Laboratories 14169 2New Productivity Suite From Varian Inc Increases Throughput for NMR Laboratories 14169 3DOR BioPharma Announces 249 4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 57734 1DOR BioPharma Announces 249 4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 57734 2DOR BioPharma Announces 249 4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 57734 3DOR BioPharma Announces 249 4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 57734 4DOR BioPharma Announces 249 4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 57734 5DOR BioPharma Announces 249 4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 57734 6Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 1Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 2Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 3Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 4Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 5Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 6Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 7Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 8